Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Basmisanil

Generic Name: Basmisanil

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₀FN_₃O_₅S

CAS Number: 1159600-41-5

Unique Ingredient Identifier: 788PET5SUA

Overview

Basmisanil has been used in trials studying the treatment and basic science of Down Syndrome.

Background

Basmisanil has been used in trials studying the treatment and basic science of Down Syndrome.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome

Phase 2

Terminated

Posted: 2022/04/01

Sponsor:Hoffmann-La Roche

ID:NCT05307679

A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

Phase 2

Completed

Posted: 2016/11/03

Sponsor:Hoffmann-La Roche

ID:NCT02953639

A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Phase 2

Terminated

Posted: 2016/10/10

Sponsor:Hoffmann-La Roche

ID:NCT02928393

Basmisanil Positron Emission Tomography Study in Japanese Volunteers

Phase 1

Completed

Posted: 2015/08/27

Sponsor:Hoffmann-La Roche

ID:NCT02534207

A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age

Phase 2

Terminated

Posted: 2015/06/30

Sponsor:Hoffmann-La Roche

ID:NCT02484703

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy